These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26311508)

  • 21. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches.
    Fuchs S; Aricha R; Reuveni D; Souroujon MC
    J Autoimmun; 2014 Nov; 54():51-9. PubMed ID: 24970384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astilbin ameliorates experimental autoimmune myasthenia gravis by decreased Th17 cytokines and up-regulated T regulatory cells.
    Meng QF; Zhang Z; Wang YJ; Chen W; Li FF; Yue LT; Zhang CJ; Li H; Zhang M; Wang CC; Zhang P; Chen H; Duan RS; Sun SM; Li YB
    J Neuroimmunol; 2016 Sep; 298():138-45. PubMed ID: 27609287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of experimental autoimmune uveoretinitis by regulatory dendritic cells in mice.
    Usui Y; Takeuchi M; Hattori T; Okunuki Y; Nagasawa K; Kezuka T; Okumura K; Yagita H; Akiba H; Goto H
    Arch Ophthalmol; 2009 Apr; 127(4):514-9. PubMed ID: 19365033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent.
    Menon RT; Feferman T; Aricha R; Souroujon MC; Fuchs S
    J Neuroimmunol; 2008 Sep; 201-202():128-35. PubMed ID: 18632163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-beta.
    Kong QF; Sun B; Bai SS; Zhai DX; Wang GY; Liu YM; Zhang SJ; Li R; Zhao W; Sun YY; Li N; Wang Q; Peng HS; Jin LH; Li HL
    J Neuroimmunol; 2009 Feb; 207(1-2):83-91. PubMed ID: 19174310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential.
    Gur-Wahnon D; Mizrachi T; Wald-Altman S; Al-Roof Higazi A; Brenner T
    J Autoimmun; 2014 Aug; 52():36-43. PubMed ID: 24423642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells.
    Yang CL; Zhang P; Liu RT; Zhang N; Zhang M; Li H; Du T; Li XL; Dou YC; Duan RS
    J Neuroinflammation; 2019 Dec; 16(1):282. PubMed ID: 31884963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity.
    Zhang P; Yang CL; Du T; Liu YD; Ge MR; Li H; Liu RT; Wang CC; Dou YC; Duan RS
    J Neuroinflammation; 2021 Oct; 18(1):244. PubMed ID: 34702288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.
    Aricha R; Reuveni D; Fuchs S; Souroujon MC
    J Autoimmun; 2016 Feb; 67():57-64. PubMed ID: 26489998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low and high doses of ursolic acid ameliorate experimental autoimmune myasthenia gravis through different pathways.
    Xu H; Zhang M; Li XL; Li H; Yue LT; Zhang XX; Wang CC; Wang S; Duan RS
    J Neuroimmunol; 2015 Apr; 281():61-7. PubMed ID: 25867469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immature Exosomes Derived from MicroRNA-146a Overexpressing Dendritic Cells Act as Antigen-Specific Therapy for Myasthenia Gravis.
    Yin W; Ouyang S; Luo Z; Zeng Q; Hu B; Xu L; Li Y; Xiao B; Yang H
    Inflammation; 2017 Aug; 40(4):1460-1473. PubMed ID: 28523463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential of atorvastatin-modified dendritic cells in experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells and NKR-P1(+) cells.
    Xu H; Li XL; Yue LT; Li H; Zhang M; Wang S; Wang CC; Duan RS
    J Neuroimmunol; 2014 Apr; 269(1-2):28-37. PubMed ID: 24565076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-bet deficiency decreases susceptibility to experimental myasthenia gravis.
    Liu R; Hao J; Dayao CS; Shi FD; Campagnolo DI
    Exp Neurol; 2009 Dec; 220(2):366-73. PubMed ID: 19818352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO.
    Kong QF; Sun B; Wang GY; Zhai DX; Mu LL; Wang DD; Wang JH; Li R; Li HL
    Eur J Immunol; 2009 Mar; 39(3):800-9. PubMed ID: 19283707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin attenuates autoimmune disease of the neuromotor system in animal models of myasthenia gravis.
    Cui Y; Chang L; Wang C; Han X; Mu L; Hao Y; Liu C; Zhao J; Zhang T; Zhang H; Zhang Y; Liu Y; Zhao W; Wang J; Liu X; Sun B; Wang G; Kong Q; Han J; Li H
    Int Immunopharmacol; 2019 Oct; 75():105822. PubMed ID: 31437793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18.
    Im SH; Barchan D; Maiti PK; Raveh L; Souroujon MC; Fuchs S
    FASEB J; 2001 Oct; 15(12):2140-8. PubMed ID: 11641240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous immunoglobulin suppresses experimental myasthenia gravis: immunological mechanisms.
    Zhu KY; Feferman T; Maiti PK; Souroujon MC; Fuchs S
    J Neuroimmunol; 2006 Jul; 176(1-2):187-97. PubMed ID: 16730380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting HIF-1α alleviates the inflammatory responses and rebuilds the CD4
    Yu L; Ran H; Lu Y; Ma Q; Huang H; Liu W
    Life Sci; 2024 Jan; 336():122287. PubMed ID: 37995933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin ameliorates experimental autoimmune myasthenia gravis by diverse immune cells.
    Wang S; Li H; Zhang M; Yue LT; Wang CC; Zhang P; Liu Y; Duan RS
    Neurosci Lett; 2016 Jul; 626():25-34. PubMed ID: 27181511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.